A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. The five-year survival rate of HNSCC has not improved even with major technological advancements in surgery and chemotherapy. Currently, docetaxel, cisplatin, and 5-fluoruracil (TPF) treatment has been the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Qi, Fang, Jugao, Huang, Zhigang, Yang, Yifan, Lian, Meng, Liu, Honggang, Zhang, Yixiang, Ye, Junhui, Hui, Xinjie, Wang, Yejun, Ying, Ying, Zhang, Qing, Cheng, Yingduan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107664/
https://www.ncbi.nlm.nih.gov/pubmed/30139993
http://dx.doi.org/10.1038/s41598-018-31027-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107664/
https://www.ncbi.nlm.nih.gov/pubmed/30139993
http://dx.doi.org/10.1038/s41598-018-31027-y

Ejemplares similares